DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION

Overview

INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION is the #11 most commonly reported adverse reaction for DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE, manufactured by Major Pharmaceuticals. There are 44 FDA adverse event reports linking DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE to INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION. This represents approximately 2.0% of all 2,218 adverse event reports for this drug.

Patients taking DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE who experience inappropriate schedule of product administration should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION is a less commonly reported adverse event for DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE, but still significant enough to appear in the safety profile.

Other Side Effects of DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE

In addition to inappropriate schedule of product administration, the following adverse reactions have been reported for DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE:

• PAIN — 70 reports
• FATIGUE — 68 reports
• NAUSEA — 63 reports
• RASH — 59 reports
• DIARRHOEA — 56 reports
• HEADACHE — 54 reports
• PRODUCT DOSE OMISSION ISSUE — 48 reports
• PRURITUS — 46 reports
• PNEUMONIA — 45 reports
• COVID 19 — 44 reports

Other Drugs Associated with INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION

The following drugs have also been linked to inappropriate schedule of product administration in FDA adverse event reports:

Does DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE cause INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION?

INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION has been reported as an adverse event in 44 FDA reports for DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION with DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE?

INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION accounts for approximately 2.0% of all adverse event reports for DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE, making it a notable side effect.

What should I do if I experience INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION while taking DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE?

If you experience inappropriate schedule of product administration while taking DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages